SBI Life Insurance Company
Lowest-cost, highest-persistency
- Last close
- ₹1,735.00
- 29 Sept 2026 · reference
- 1D · 1M
- +0.4% · −1.5%
- price-only
- Weight
- 1.1%
- 31 Jul 2026 · Aug rank 26
- Thesis review
- 8 Sep 2026
- Why We Own, p38
Approved description
India's largest private life insurer (55.3% owned by State Bank of India), with a 22.9% private-sector market share on individual rated premium and 25.5% on individual new business in FY26. FY26 APE was Rs 24,270 crore (+13%), VNB Rs 6,670 crore at a 27.5% margin, embedded value Rs 80,790 crore (+15%) and AUM Rs 4.87 lakh crore. SBI's 22,000+ branch network supplies ~60% of APE via bancassurance, supplemented by a fast-growing agency channel; the product mix is ULIP-heavy (60% of FY26 APE) but non-par rose to 49% of Q1FY27 APE.
- 01Growth re-accelerating on distribution diversification: Q1FY27 APE +36% (individual rated NBP +14%, agency +20%, banca +10%) and Aug-2026 individual APE +21.8%, the highest among the four listed private insurers.
- 02Margin resilience despite GST/ITC loss: VNB margin 26.2% in Q1FY27 (27.4% ex-GST) with guidance of 26-28% for FY27; non-par share of APE rose to 49% from 38% and pure protection APE +41%.
- 03Scale and cost leadership: largest private insurer (22.9% private IRP share), FY26 EV Rs 80,790 cr (+15%) with 19.7% operating RoEV, solvency 1.96x, lowest mis-selling ratio (0.02%) and 87.7% 13-month persistency.
- 04Earnings visibility: Axis Direct forecasts EPS of Rs 28.3/37.5 for FY27/FY28 (23% CAGR from FY26's Rs 24.63) as the back book unwinds; street TPs Rs 2,350-2,600 vs Rs 1,732 (27-50% upside).
- 05Cheapest large-cap access to the SBI franchise: SBI's 22,000+ branches (60% of APE) at 1.8x FY27E EV, a lower multiple than Max Financial (1.9x) with a stronger balance sheet and no holdco/structure risk.
Reference close, with results-period markers
- 1Q Sep-25 end · 30 Sept 2025
- 2Q Dec-25 end · 31 Dec 2025
- 3Q Mar-26 end · 31 Mar 2026
- 4Q Jun-26 end · 30 Jun 2026
Quality score, technicals and Buoyant Score
Computing the scorecard…
Latest quarter · Q Jun-26
| Line (₹ cr) | Q Jun-26 | YoY | QoQ |
|---|---|---|---|
| Net Sales | 20,078 | +16.9% | −27.5% |
| Operating Profit | -25,501 | loss widened | turned loss making |
| Net Profit | 725 | +22.1% | −9.9% |
Reported vs internal estimate: internal quarterly estimates are not in the supplied package; consensus feed not licensed. YoY/QoQ per PRD §12.5 (transitions, not %, on non-positive bases).
Position and valuation context
Life-insurance preset: APE, VNB, VNB margin, embedded value, persistency, solvency; P/EV. Standard P&L margins are not meaningful.
Sell-side targets are third-party views, not Buoyant's; the upside is recomputed on our reference close, so it differs from the figure printed at the broker's price date.
Valuation range
No headline target on this page; the book quotes the thesis and the risk rather than a target.
What we watch
- H1FY27 results (late Oct-2026): margin recovery toward 27-28% guidance as group business normalises and non-par mix stays high.
- Monthly IRDAI new-business data (Sep-Oct-2026) confirming 20%+ individual APE growth ahead of peers.
- Any IRDAI/GST Council move to restore input-tax credit for insurers, which would reverse the ~120 bps GST margin drag.
- Bancassurance dependence: SBI channel is ~60% of FY26 APE (47% in Q1FY27); any regulatory cap on banca share or a change in SBI's priorities would cut growth.
- ULIP/market sensitivity: ULIPs were 60% of FY26 APE (46% in Q1FY27); an equity-market correction would slow ULIP sales and compress the mix-driven margin, while 61-month persistency fell to 58.4% from 63.6%.
- GST/ITC and product regulation: exemption from 22-Sep-2025 with ITC withdrawal cost ~120 bps of Q1FY27 margin (27.4% ex-GST vs 26.2% reported); further surrender-value or commission rules could pressure VNB.